1. Balkwell FR, Lee A, Aldam G et al. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferon Cancer Res 1996 46: 3990–3993
2. Asher A, Mule JJ, Reichert CM et al. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo J Immunol 1987 138: 963–974
3. Renard N, Lienard D, Lespagnard L et al. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumor necrosis factor alpha (rTNA alpha) Int J Cancer 1994 57: 656–663
4. Fukumura D, Salehi HA, Witwer B et al. Tumor necrosis factor alpha–induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain Cancer Res 1995 55: 4824–4829
5. Hallahan DE, Vokes EE, Rubin SJ et al. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy Cancer J Sci Am 1995 1: 204–209